logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Anthony A. Portale

University of California System
H指数:50
被引数:9,156

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Current Practices in Monitoring Children and Adults With X-linked Hypophosphatemia: A Global Survey of Expert Experience

X-连锁低磷酸盐血症儿童和成人监测的当前实践：一项全球专家经验调查

The Journal of Clinical Endocrinology & Metabolism
IF5.1
2025-03-201
OA
Dalal S Ali; Farah Alsarraf; Hajar Abu Alrob; R Todd Alexander; Abdulrahman Almoulia; Natasha M Appelman-Dijkstra; Signe Sparre Beck-Nielsen; Martin Biosse-Duplan; Maria Luisa Brandi; Thomas O Carpenter; Catherine Chaussain; Martine Cohen-Solal; Rachel K Crowley; Karel Dandurand; Pablo Florenzano; Claudia Gagnon; Paul Goodyer; Chelsey Grimbly; Salma Hussein; Erik A Imel; Suzanne M Jan de Beur; Muhammad K Javaid; Anna Lehman; Willem F Lems; E Michael Lewiecki; Ciara McDonnell; Reza D Mirza; Emmett Morgante; Anthony A Portale; Yumie Rhee; Heide Siggelkow; Laura L Tosi; Leanne M Ward; Gordon Guyatt; Aliya A Khan
Nephrocalcinosis and kidney function in children and adults with X-linked hypophosphatemia: baseline results from a large longitudinal study
JOURNAL OF BONE AND MINERAL RESEARCH
IF5.9
2024-08-161
OAAI
Portale, Anthony A.; Ward, Leanne; Dahir, Kathryn; Florenzano, Pablo; Ing, Steven W.; de Beur, Suzanne M. Jan; Martin, Regina M.; Meza-Martinez, Adriana, I; Paloian, Neil; Ashraf, Ambika; Dixon, Bradley P.; Khan, Aliya; Langman, Craig; Chen, Angel; Wang, Christine; Roberts, Mary Scott; Tandon, P. K.; Bedrosian, Camille; Imel, Erik A.
Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period

Burosumab与X连锁低磷血症患儿的常规治疗: 开放标签，3期延长期的结果

JBMR PLUS
IF2.4
2024-01-043
OAAI
Ward, Leanne M.; Hoegler, Wolfgang; Glorieux, Francis H.; Portale, Anthony A.; Whyte, Michael P.; Munns, Craig F.; Nilsson, Ola; Simmons, Jill H.; Padidela, Raja; Namba, Noriyuki; Cheong, Hae, II; Sochett, Etienne; Muroya, Koji; Tanaka, Hiroyuki; Pitukcheewanont, Pisit; Gottesman, Gary S.; Biggin, Andrew; Perwad, Farzana; Chen, Angel; Merritt, John Lawrence; Imel, Erik A.
Burosumab vs Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Subgroup Analysis by Dose Level

Burosumab与磷酸盐/活性维生素d在小儿X连锁低磷血症中的作用: 剂量水平的亚组分析

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
IF5.1
2023-04-219
OA
Imel, Erik A.; Glorieux, Francis H.; Whyte, Michael P.; Portale, Anthony A.; Munns, Craig F.; Nilsson, Ola; Simmons, Jill H.; Padidela, Raja; Namba, Noriyuki; Cheong, Hae Il; Pitukcheewanont, Pisit; Sochett, Etienne; Hoegler, Wolfgang; Muroya, Koji; Tanaka, Hiroyuki; Gottesman, Gary S.; Biggin, Andrew; Perwad, Farzana; Chen, Angel; Roberts, Mary Scott; Ward, Leanne M.
Efficacy of Burosumab in Adults with X-linked Hypophosphatemia (XLH): A Post Hoc Subgroup Analysis of a Randomized Double-Blind Placebo-Controlled Phase 3 Study
CALCIFIED TISSUE INTERNATIONAL
IF3.2
2022-08-0413
PRE
Brandi, Maria Luisa; Jan de Beur, Suzanne; Briot, Karine; Carpenter, Thomas; Cheong, Hae Il; Cohen-Solal, Martine; Crowley, Rachel K.; Eastell, Richard; Imanishi, Yasuo; Imel, Erik A.; Ing, Steven W.; Insogna, Karl; Ito, Nobuaki; Javaid, Kassim; Kamenicky, Peter; Keen, Richard; Kubota, Takuo; Lachmann, Robin H.; Perwad, Farzana; Pitukcheewanont, Pisit; Portale, Anthony; Ralston, Stuart H.; Tanaka, Hiroyuki; Weber, Thomas J.; Yoo, Han-Wook; Sun, Wei; Williams, Angela; Nixon, Annabel; Takeuchi, Yasuhiro
Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia

与常规疗法相比，Burosumab对X连锁低磷血症的年龄较小和年龄较大的儿童的影响

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
IF5.1
2022-05-0945
OA
Ward, Leanne M.; Glorieux, Francis H.; Whyte, Michael P.; Munns, Craig F.; Portale, Anthony A.; Hoegler, Wolfgang; Simmons, Jill H.; Gottesman, Gary S.; Padidela, Raja; Namba, Noriyuki; Cheong, Hae Il; Nilsson, Ola; Mao, Meng; Chen, Angel; Skrinar, Alison; Roberts, Mary Scott; Imel, Erik A.
Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia
CALCIFIED TISSUE INTERNATIONAL
IF3.2
2021-01-2331
OAAI
Padidela, Raja; Whyte, Michael P.; Glorieux, Francis H.; Munns, Craig F.; Ward, Leanne M.; Nilsson, Ola; Portale, Anthony A.; Simmons, Jill H.; Namba, Noriyuki; Cheong, Hae Il; Pitukcheewanont, Pisit; Sochett, Etienne; Hogler, Wolfgang; Muroya, Koji; Tanaka, Hiroyuki; Gottesman, Gary S.; Biggin, Andrew; Perwad, Farzana; Williams, Angela; Nixon, Annabel; Sun, Wei; Chen, Angel; Skrinar, Alison; Imel, Erik A.
Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period

Burosumab对X连锁低磷血症成人的持续有益作用: 24周双盲安慰剂对照后24周治疗持续时间的结果

CALCIFIED TISSUE INTERNATIONAL
IF3.2
2019-06-04110
OAAI
Portale, Anthony A.; Carpenter, Thomas O.; Brandi, Maria Luisa; Briot, Karine; Cheongs, Hae Il; Cohen-Solal, Martine; Crowley, Rachel; De Beur, Suzanne Jan; Eastell, Richard; Imanishi, Yasuo; Imel, Erik A.; Ing, Steven; Ito, Nobuaki; Javaid, Muhammad; Kamenicky, Peter; Keen, Richard; Kubota, Takuo; Lachmann, Robin; Perwad, Farzana; Pitukcheewanont, Pisit; Ralston, Stuart H.; Takeuchi, Yasuhiro; Tanaka, Hiroyuki; Weber, Thomas J.; Yoo, Han-Wook; Zhang, Lin; Theodore-Oklota, Christina; Mealiffe, Matt; Martin, Javier San; Insogna, Karl
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial
LANCET
IF88.5
2019-06-01242
OAAI
Imel, Erik A.; Glorieux, Francis H.; Whyte, Michael P.; Munns, Craig F.; Ward, Leanne M.; Nilsson, Ola; Simmons, Jill H.; Padidela, Raja; Namba, Noriyuki; Cheong, Hae Il; Pitukcheewanont, Pisit; Sochett, Etienne; Hoegler, Wolfgang; Muroya, Koji; Tanaka, Hiroyuki; Gottesman, Gary S.; Biggin, Andrew; Perwad, Farzana; Mao, Meng; Chen, Chao-Yin; Skrinar, Alison; San Martin, Javier; Portale, Anthony A.
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis

一项随机，双盲，安慰剂对照的3期试验，评估了Anti-FGF23抗体Burosumab在X连锁低磷血症成人中的疗效: 第24周的初步分析

JOURNAL OF BONE AND MINERAL RESEARCH
IF5.9
2018-06-26229
OAAI
Insogna, Karl L.; Briot, Karine; Imel, Erik A.; Kamenicky, Peter; Ruppe, Mary D.; Portale, Anthony A.; Weber, Thomas; Pitukcheewanont, Pisit; Cheong, Hae Il; de Beur, Suzanne Jan; Imanishi, Yasuo; Ito, Nobuaki; Lachmann, Robin H.; Tanaka, Hiroyuki; Perwad, Farzana; Zhang, Lin; Chen, Chao-Yin; Theodore-Oklota, Christina; Mealiffe, Matt; Martin, Javier San; Carpenter, Thomas O.

研究方向

暂未获取到该数据
F
Farzana Perwad
H 指数:22论文数:62被引数:2,853
E
Erik A. Imel
H 指数:43论文数:226被引数:8,008
T
Thomas O. Carpenter
H 指数:58论文数:274被引数:1.1万
L
Leanne M. Ward
H 指数:60论文数:302被引数:1.8万
R
Raja Padidela
H 指数:28论文数:183被引数:3,177
W
Wolfgang Högler
H 指数:54论文数:351被引数:9,919
M
Michael P. Whyte
H 指数:86论文数:673被引数:2.9万
B
Bradley A. Warady
H 指数:89论文数:847被引数:3.1万
H
Hae Il Cheong
H 指数:45论文数:359被引数:7,263
P
Pisit Pitukcheewanont
H 指数:31论文数:132被引数:4,070